Top Warren Buffett Companies To Watch For 2014

BALTIMORE (Stockpickr) -- The Fed is shutting the tap this week, ending the QE3 bond-.buying program that's arguably been one of the biggest structural drivers of the rally in stocks over the past couple of years. Or at least that's the plan.

Must Read: Warren Buffett's Top 10 Dividend Stocks

While the Fed's press release calls for an end to quantitative easing, this isn't the first time they've called an end to the buying spree before starting another one. With key data, such as forward inflation lower than it's been since Operation Twist in 2011, the possibility of QE4 (or QE5, depending on how you've been counting) is becoming more palpable by the day.

So far, stocks have had a pretty tepid reaction to the end of QE3. The decision was largely already baked into stock prices. As I write, there are some big-name trades that are starting to look very attractive as a result. Today, we're taking a technical look at five large-cap stocks worth trading this week.

Top 5 Financial Stocks To Buy Right Now: FuelCell Energy Inc.(FCEL)

FuelCell Energy, Inc., together with its subsidiaries, engages in the development, manufacturing, and sale of high temperature fuel cells for clean electric power generation primarily in South Korea, the United States, Germany, Canada, and Japan. The company offers proprietary carbonate Direct FuelCell Power Plants that electrochemically produce electricity from hydrocarbon fuels, such as natural gas and biogas. Its fuel cells operate on a range of hydrocarbon fuels, including natural gas, renewable biogas, propane, methanol, coal gas, and coal mine methane. The company also develops carbonate fuel cells, planar solid oxide fuel cell technology, and other fuel cell technologies. It provides its products to universities; manufacturers; mission critical institutions, such as correction facilities and government installations; hotels; and natural gas letdown stations, as well as to customers who use renewable biogas for fuel, including municipal water treatment facilities, br eweries, and food processors. The company was founded in 1969 and is headquartered in Danbury, Connecticut.

Advisors' Opinion:

• [By Dan Burrows]

  Like fellow fuel-cell stocks Ballard Power Systems (BLDP) and FuelCell Energy (FCEL), PLUG stock trades wildly from headline to headline. The volatility alone makes Plug Power too risky because it’s far too easy to buy high.

Top Warren Buffett Companies To Watch For 2014: Affymetrix Inc.(AFFX)

Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets primarily in the United States, Europe, Japan. The company provides integrated GeneChip microarray platform, which includes disposable DNA probe arrays (chips) consisting of nucleic acid sequences, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. It also offers GeneTitan, an instrument system that runs genotyping and gene expression array plates; and GeneAtlas, an instrument for low-to-medium throughput that provides hybridization and array processing with microwell-based labware, as well as a line of multiplex assays to serve the discovery and the validation markets. In addition, the company provides reagent kits, including ExoSAP-IT fo r a reagent for the clean-up of polymerase chain reaction (PCR) products used in downstream applications, such as DNA sequencing or single-nucleotide polymorphisms analysis; and HotStart-IT reagents that utilize a novel primer binding protein to inhibit primer dimer formation with results in sensitive and consistent amplification for PCR. Its products are used primarily in genotyping and gene expression applications. The company sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies; academic research centers, government research laboratories, private foundation laboratories, and clinical reference laboratories in North America and Europe, as well as through life science supply specialists acting as authorized distributors in Latin America, the Middle East, and Asia Pacific regions. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.

Advisors' Opinion:

• [By Rich Duprey]

  It's in the genes
  Elsewhere in the market, however,�Affymetrix (NASDAQ: AFFX  ) tumbled more than 13% after preannouncing first-quarter earnings that missed even its own expectations. It blamed "headwinds" in its gene expression business everywhere it does business, though it suffered a particular shortfall in Japan. The Fool's Sean Williams thinks that may indicate more than a one-off performance issue because of the global nature of the miss Affymetrix suffered.

Top Warren Buffett Companies To Watch For 2014: Rentech Inc (RTK)

Rentech, Inc. (Rentech), incorporated in 1981, is a provider of clean energy solutions. The Company owns and operates a nitrogen fertilizer plant in East Dubuque, Illinois, that manufactures and sells natural gas-based nitrogen fertilizer products within the corn-belt region in the United States. It is developing energy projects to produce certified synthetic fuels and electric power from carbon-containing materials, such as biomass, waste and fossil resources. Its technologies can produce synthesis gas (syngas) from biomass and waste materials, and convert syngas from its own or other gasification technologies into complex hydrocarbons (the Rentech Process) that are then upgraded into fuels using refining technology that it licenses. In addition to developing projects using these technologies, it is pursuing the licensing of its technologies to developers of projects that are expected to produce fuels and/or power. In May 2011, it acquired majority interest in ClearFuels Technology Inc. In May 2013, Rentech Inc acquired the entire share capital of Fulghum Fibres Inc. In August 2013, Rentech Inc announced that a subsidiary of the Company closed the sale of approximately 450 acres in Natchez, Mississippi to Adams County, Mississippi.

The Rentech Process is a technology based on Fischer-Tropsch (FT) chemistry, which converts syngas that can be produced from a range of biomass, waste and fossil resources into hydrocarbons. These hydrocarbons can be processed and upgraded into synthetic fuels, such as military and commercial jet fuels and low sulfur diesel fuel, as well as waxes and chemicals. Unlike some other alternative transportation fuels, such as ethanol, fuels produced from the Rentech Process can be transported and used in existing infrastructure, including pipelines and engines without blending restrictions. Its technology portfolio also includes the Rentech-SilvaGas biomass gasification technology (the Rentech-SilvaGas Technology), which enables it to offer integrated technologies t! hat can convert biomass and wastes to syngas and into clean fuels and electric power.

The Rentech Process can produce synthetic diesel fuels (RenDiesel1 fuels), which are clean burning having lower emissions of regulated pollutants, such as nitrogen oxides, sulfur oxides and particulate matter, than traditional petroleum-based diesel fuels. The Rentech Process also can produce synthetic jet fuel (RenJet fuel), which when blended with conventional jet fuel meet jet fuel specifications for military jet fuel and commercial Jet A and Jet A-1 fuels. It is developing a proposed project near Natchez, Mississippi (the Natchez Project) designed to produce approximately 30,000 barrels per day of synthetic fuels and chemicals and approximately 120 megawatts of power. It is evaluating alternative configurations for the Natchez site, which would initially be smaller in scale. The alternate configurations may use various feed-stocks alone or in various combinations, and include proportions of waxes and chemicals as products.

The Company owns, through its wholly owned subsidiary, Rentech Energy Midwest Corporation (REMC), a nitrogen fertilizer manufacturing plant that uses natural gas as its feedstock to produce syngas and then nitrogen fertilizer products. The products, the Company can produce include renewable synthetic diesel and jet fuels, naphtha and power from biomass resources; synthetic diesel and jet fuels, naphtha and power from fossil or fossil and biomass resources, and paraffinic waxes, solvents and specialty chemicals.

The Company competes with ExxonMobil, the Royal Dutch/Shell group, Statoil, BP and Sasol.

Advisors' Opinion:

• [By Travis Hoium]

  What: Shares of fertilizer and renewable energy company Rentech (NASDAQ: RTK  ) jumped 17% today after the company announced an acquisition.

• [By Rich Duprey]

  Alternative energy specialist�Rentech� (NASDAQ: RTK  ) �will be�buying back�up to $25 million worth of company stock through the rest of the year, the board of directors announced Monday.

• [By Robert Rapier] While the MLP space is dominated by the oil and gas sector, in last week’s article we began to explore some of the more exotic master limited partnership offerings. This week we continue our exploration of nontraditional MLPs by looking at the partnerships supplying fertilizer.
  
  Rentech (Nasdaq: RTK) has been around for more than a decade, and it has shifted strategies several times. Full disclosure: Rentech’s Chief Technology Officer Harold Wright is a former manager of mine when we were both at ConocoPhillips, and I have visited Rentech’s facility in Commerce City, Colorado.
  
  For most of Rentech’s existence, the company has sought to commercialize alternative fuels. At one time it had ambitions to build a large coal-to-liquids (CTL) plant, but federal legislation ultimately nudged it instead into the biomass-to-liquids (BTL) space. The company did build a BTL demonstration plant, but ultimately shut it down and has now refocused its efforts on becoming “one of the largest wood processing companies in the world.”
  
  During its interesting journey as a company, Rentech acquired two ammonia nitrogen fertilizer facilities, which turned out to be a profit center that funded the alternative energy research. In November 2011, Rentech spun off this fertilizer business into an MLP called Rentech Nitrogen Partners LP (NYSE: RNF).
  
  In the months leading to the spin-off, RTK’s market capitalization was about $200 million. Rentech maintained 60 percent ownership of RNF, and three months after the spin-off RTK’s market cap had risen to $400 million, while investors had bid RNF up to $1 billion. Interestingly, RTK’s share of RNF was worth more than RTK’s entire market cap, a situation that persists. The market currently values Rentech at $482 million, while the valuation of Rentech Nitrogen Partners makes RTK’s 60 percent stake in RNF worth slightly more than $600 million — another illu

Top Warren Buffett Companies To Watch For 2014: Helios Advantage Income Fund Inc. (HAV)

Helios Advantage Income Fund, Inc. is a close ended fixed income mutual fund launched and managed by Brookfield Investment Management Inc. The fund invests in the fixed income markets of the United States. It invests a majority of its assets in below investment grade debt securities, which are bonds rated Ba1 or lower by Moody's Investors Service, Inc., BB+ or lower by Standard & Poor's Ratings Group. The fund benchmarks the performance of its portfolio against the Barclays Capital U.S. Corporate High Yield Index and the Barclays Capital Ba U.S. High Yield Index. It was formerly known as RMK Advantage Income Fund, Inc. Helios Advantage Income Fund, Inc. was formed on November 8, 2004 and is domiciled in the United States.

Advisors' Opinion:

• [By Tom Stoukas]

  Havas SA (HAV) surged 6 percent to 5.82 euros, its largest rally in 14 months. The French advertising company reported first-half profit of 58 million euros ($77 million), beating the average analyst estimate of 55.9 million euros.

Top Warren Buffett Companies To Watch For 2014: Spectrum Pharmaceuticals Inc.(SPPI)

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company, primarily focuses on oncology and hematology. The company engages in acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. It markets Zevalin, a prescribed form of cancer therapy, radioimmunotherapy; and Fusilev, a novel folate analog formulation and the pharmacologically active isomer of the racemic compound, calcium leucovorin. The company?s drugs in late stage development include Apaziquone, an anti-cancer agent; and Belinostat, a histone deacytelase inhibitor. Its drugs in development also include Ozarelix a luteinizing hormone releasing hormone antagonist, which is in Phase II clinical stage; SPI-1620, a peptide agonist of endothelin B receptors, which is in Phase I clinical stage; and RenaZorb, a lanthanum-based nanoparticle phosphate binding agent, which is in preclinical stage. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is based in Henderson, Nevada.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 biotechnology player that's starting to move within range of triggering a near-term breakout trade is Spectrum Pharmaceuticals (SPPI) which develops and commercializes oncology and hematology drug products. This stock has traded off a bit so far in 2014, with shares off by 7.3%.

  If you take a glance at the chart for Spectrum Pharmaceuticals, you'll see that this stock has been uptrending over the last month and change, with shares moving higher from its low of $6.75 to its recent high of $8.50 a share. During that uptrend, shares of SPPI have been making mostly higher lows and higher highs, which is bullish technical price action. This move has now pushed shares of SPPI within range of triggering a near-term breakout trade above some key overhead resistance levels.

  Traders should now look for long-biased trades in SPPI if it manages to break out above some near-term overhead resistance levels at $8.25 to $8.50 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 1.07 million shares. If that breakout gets underway soon, then SPPI will set up to re-test or possibly take out its next major overhead resistance levels at $9.27 to its 52-week high at $10.32 a share. Any high-volume move above $10.32 will then give SPPI a chance to re-fill some of its previous gap-down-day zone from March of 2013 that started at $12.47 a share.

  Traders can look to buy SPPI off weakness to anticipate that breakout and simply use a stop that sits right below its recent double bottom support levels at $7.82 to $7.81 a share or right below its 50-day moving average of $7.69 a share. One can also buy SPPI off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  Read More: 5 Hated Earnings Stocks You Should Love

Top Warren Buffett Companies To Watch For 2014: Matahari Department Store Tbk PT (LPPF)

PT Matahari Department Store Tbk operates as a multi-format retailer. The Company, based in Indonesia, operates as the Department Store division of Matahari Putra Prima. The Matahari Group is Indonesia's multi-format retailer with core retail businesses in fashion and household groceries businesses targeted for middle - upper middle consumers throughout the country. Advisors' Opinion:

• [By Emma O��rien]

  PT Matahari Department Store (LPPF), Indonesia�� largest retailer, climbed 7.7 percent to 14,000 rupiah after the stock was added to the MSCI Emerging Markets Index.